drugset / Trial / NCT05152498

Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)

NCT05152498 ↗

Phase 0 Unknown 142 enrolled Beijing Ditan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The treatment of HBV related hepatocellular carcinoma has always been a worldwide problem. The aim of this study is to alleviate the progression of hepatitis B related hepatocellular carcinoma by the Chinese medicine "Fu Zheng Jie Du Hua Yu" Principle.

Timeline

Start
2021-01-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fu Zheng Jie Du Hua Yu Traditional medicine (herbal / TCM) — —